Liensinine was used to block mitophagy in CRC cells (Figure S3A, Supporting Information), and GPR176‐KD induced cell cycle arrest and cell apoptosis, and inhibited cell proliferation, while liensinine reversed these effects. The gene discussed is GPR176; the disease is colorectal carcinoma.